Chen Yang
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- RNA modifications and cancer 6
- Co-authors
- Wenxin Qin (18 shared papers)Cun Wang (16 shared papers)René Bernards (4 shared papers)Andrew X. Zhu (2 shared papers)Haojie Jin (9 shared papers)Xiaowen Huang (8 shared papers)Linmeng Zhang (6 shared papers)Yuanyuan Lv (5 shared papers)
- Journals
- Microchemical Journal (4 papers)Scientific Reports (4 papers)Cancer Imaging (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)Frontiers in Aging Neuroscience (2 papers)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Chen Yang
117 papers receiving 3.8k citations
Chen Yang's Hit Papers
Peers
Comparison fields: 5 of 151
- Cancer Research 1.0k
- Hepatology 252
- Oncology 652
- Molecular Biology 1.7k
- Pulmonary and Respiratory Medicine 429
Countries citing papers authored by Chen Yang
This map shows the geographic impact of Chen Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen Yang more than expected).
Fields of papers citing papers by Chen Yang
This network shows the impact of papers produced by Chen Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen Yang. The network helps show where Chen Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Chen Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 125 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Evolving therapeutic landscape of advanced hepatocellular carcinoma Hit paper breakdown → | 2022 | 499 |
| 2 | circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity Hit paper breakdown → | 2021 | 424 |
| 3 | 2019 | 285 | |
| 4 | Precision treatment in advanced hepatocellular carcinoma Hit paper breakdown → | 2024 | 222 |
| 5 | 2020 | 186 | |
| 6 | 2007 | 167 | |
| 7 | 2020 | 156 | |
| 8 | 2018 | 152 | |
| 9 | 2017 | 134 | |
| 10 | 2019 | 98 | |
| 11 | 2016 | 74 | |
| 12 | 2016 | 70 | |
| 13 | 2023 | 69 | |
| 14 | 2018 | 61 | |
| 15 | 2010 | 59 | |
| 16 | 2022 | 59 | |
| 17 | 2021 | 43 | |
| 18 | 2019 | 40 | |
| 19 | 2015 | 39 | |
| 20 | Downregulation of ACSM3 promotes metastasis and predicts poor prognosis in hepatocellular carcinoma. | 2017 | 37 |
About Chen Yang
Chen Yang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Cancer Research and Physiology, having authored 125 papers that have together received 3.8k indexed citations. Recurring topics across this work include Atmospheric chemistry and aerosols (11 papers), Cancer Genomics and Diagnostics (6 papers), RNA modifications and cancer (6 papers), Atmospheric Ozone and Climate (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Cancer-related molecular mechanisms research (5 papers), Air Quality Monitoring and Forecasting (5 papers) and Spectroscopy and Laser Applications (5 papers). The work is most often cited by research in Cancer Research (1.0k citations), Hepatology (252 citations), Oncology (652 citations), Molecular Biology (1.7k citations) and Pulmonary and Respiratory Medicine (429 citations). Chen Yang has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Wenxin Qin, Cun Wang, René Bernards, Andrew X. Zhu, Haojie Jin, Xiaowen Huang, Linmeng Zhang, Yuanyuan Lv, Hailin Zhang and Chengtao Yu. Their work appears in journals such as Microchemical Journal, Scientific Reports, Cancer Imaging, Cancer Chemotherapy and Pharmacology and Frontiers in Aging Neuroscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.